Activation of the type I insulin-like growth factor receptor (IGF-IR) blocks osmotic mediated programmed cell death (PCD) in neurons. We speculated that IGF-IR activation could afford neuroprotection either by effecting the negative regulators of the death pathway, Bcl-2 and Bcl-x L , or by altering activity of the ced-3/ICE-like proteases. Here we report that osmotic stress decreases total neuronal Bcl-2 by 4-fold and that hyperosmotic PCD correlates with proteolytic processing of neuronal ced-3/ICE-like proteases. IGF-IR activation maintains normal Bcl-2 levels, and signaling via the IGF-IR:phosphatidylinositol 3-kinase pathway prevents ICE/LAP-3 and Yama/CPP32 processing. Finally, increased neuronal IGF-IR expression enhances the negative death regulator Bcl-x L . We suggest that IGF-IR signaling exerts its short-term inhibitory effects upon PCD "upstream" of both Bcl proteins and ced-3/ICE-like proteases, while chronic increased IGF-IR expression may modulate susceptibility to death signals by mediating the negative death regulator, Bcl-x L .
1 is a ubiquitous phenomenon essential for normal development and integral in the pathogenesis of many diseases (1) . Although the mechanism of mammalian PCD is not understood, comparison with nematode cell death regulators have identified two classes of death effectors: 1) a family of oncogenes which include Bcl-2, Bcl-x L , and Bax (2) and 2) a family of cysteine proteases designated as ICE (interleukin-1␤ converting enzyme)-like molecules (3, 4) . Bcl-2 encodes a protein located in mitochondrial, endoplasmic reticular, and perinuclear membranes (5) (6) (7) (8) and suppresses naturally occurring cell death (2, 9, 10) , potentially by regulating calcium flux (11) . Bcl-x L appears to function in a manner similar to Bcl-2 and is exclusively expressed in mature post-mitotic neurons (12) . In contrast, Bax heterodimerizes with Bcl-2 or Bcl-x L and enhances PCD (2, 13) . The ratio of Bcl-2 or Bcl-x L to Bax determines the susceptibility of a cell to PCD (13) , suggesting that multiple intracellular mechanisms are operative in PCD (12) .
In the nematode, the Bcl-2 analogue, ced-9, suppresses death induced by the nematode ICE analogue ced-3 (3, 14) . To date, 7 homologs of the ced-3/ICE-like family have been identified and include Yama/CPP32/apopain (15) (16) (17) , ICE-LAP3/Mch3/ CMH-1 (18) , Mch2 (19) , Nedd-2/ICH-1, Tx/ICH/ICE rel-II, FLICE/MACH-2, and ICE rel-III (20 -22) . Phylogenetic analysis reveals that Yama, ICE-LAP3, and Mch2 are closely related to ced-3 and comprise one subfamily whose members are synthesized as pro-enzymes and processed to form active heterodimeric enzymes (20, 21) . Various apoptotic stimuli activate Yama and/or ICE-LAP3; in turn, these proteases cleave a death substrate, the 116-kDa nuclear protein poly(ADP-ribose) polymerase (PARP) (23, 24) to yield an 85-kDa apoptotic fragment (23) , which is present in virtually every form of PCD examined (23, (25) (26) (27) .
Activation of the type I insulin-like growth factor receptor (IGF-IR) by IGF-I or IGF-II treatment blocks PCD in both primary neurons as well as neural cell lines (28, 29) . While IGF-IR activation clearly prevents neural cells from entering a death program, little is known about the mechanism which underlies IGF-IR neuroprotection. We have employed well characterized human neuroblastoma cell lines as in vitro model systems to examine IGF-IR rescue of neural cells from PCD (30 -34) . SH-SY5Y cells express abundant cell surface IGF-IR and secrete IGF-II, maintaining an autocrine stimulus which provides resistance to PCD following withdrawal of other mitogens (30, 31, 35, 36) . Metabolic stressors, including hyperosmotic stress, induces PCD in SH-SY5Y cells, an effect which is inhibited by addition of exogenous IGF-I or IGF-II (28, 29) . In contrast, SHEP cells express 5-fold fewer cell surface IGF-IR receptors, produce no IGF-II, and are dependent on extrinsic mitogens for survival (29, 36, 37) . We have transfected SHEP cells with human IGF-IR, stably increasing cell surface IGF-IR abundance 5-15-fold. SHEP/IGF-IR transfectants are more resistant to hyperosmotic coupled PCD and withdrawal of other mitogens, suggesting increased IGF-IR expression has resulted in a longterm alteration in PCD regulation in these cells (29) .
In the current study, we examined both the short-and longterm effects of IGF-IR activation on Bcl-2 and ced-3/ICE-like family members in SH-SY5Y, SHEP, and SHEP/IGF-IR transfectants after a hyperosmotic death stimulus. Short-term IGF-IR activation blocked hyperosmotic coupled PCD, inhibited PCD-associated changes in Bcl-2 cellular concentrations, and retarded proteolytic processing of the ced-3/ICE-like cysteine proteases. In contrast, long-term increased expression of IGF-IR increased cellular concentrations of Bcl-x L . Collectively, these data suggest that IGF-IR signaling exerts its short-term inhibitory effects upon PCD "upstream" of both Bcl and ICE-like proteins while a separable long-term effect on PCD is present following chronic increased IGF-IR expression.
MATERIALS AND METHODS
Cell Culture-SH-SY5Y and SHEP human neuroblastoma cells (38) were provided by Drs. Stephen Fisher and Valerie Castle, respectively, University of Michigan Medical Center. Transfection of SHEP cells with pSFFVNeo containing the cDNA for human IGF-IR and subsequent selection of stable SHEP/IGF-IR transfectants has been described previously (29) . All cells are cultured in Dulbecco's modified Eagle's media (DMEM) and 10% calf serum in a humidified environment of 10% CO 2 at 37°C and routinely subcultured after removal with trypsin-EDTA. SHEP/IGF-IR transfectants are maintained in media to which 200 M G-418 has been added to select for expression of neomycin-resistant plasmids.
Experimental Conditions and Protein Isolation-For each of the experiments described below, cells were plated at an initial density of 5 ϫ 10 6 cells/cm 2 in appropriate growth media and grown in 15-cm dishes to 90% confluence. Confluent SH-SY5Y cells were washed twice with DMEM, then incubated in DMEM for 12-16 h before washing again and addition of the described experimental media conditions.
For each time point and condition, adherent cells were gently rinsed 3 times in situ with ice-cold phosphate-buffered saline, pH 7.4, and combined with nonadherent cells collected in phosphate-buffered saline by centrifugation. Cells were lysed in RIPA buffer (20 mM Tris, pH 7.4, 0.1% SDS, 1% Triton X-100, 1% deoxycholate, 1 mM EDTA, 1 mM EGTA, 150 mM NaCl, to which was added 100 g/l phenylmethylsulfonyl fluoride, 5 g/l leupeptin, and 10 g/l aprotinin just prior to use) then sonicated for two 8-s continuous bursts. Protein concentration was determined using a colorimetric assay (Bio-Rad D C Protein Assay).
Immunoblot Analysis-Immunoblot analyses were performed as described previously (39) . Equal amounts of protein (60 g) were loaded for each experiment, and protein transfer was verified by staining gels with Coomassie Blue. The rabbit polyclonal antibodies to Yama/CPP32 and ICE-LAP3 were developed by Dixit and colleagues (18) ; rabbit polyclonal antibodies to Bax and Bcl-x L , mouse monoclonal antibody to Bcl-2, and horseradish peroxidase-conjugated goat anti-mouse and anti-rabbit IgG antibodies were obtained from Santa Cruz Biotechnology, Santa Cruz, CA. Nitrocellulose membranes were incubated with primary antibodies diluted 1:600 -1:1000, for 2 h, probed with secondary antibodies (1:3000 -1:10,000), and exposed following ECL reaction (Amersham) to autoradiography film (Hyperfilm-MP, Amersham). Each experiment was performed independently 3 times. Densitometric analysis of immunoblot autoradiographs was performed following digital scanning on a flat bed scanner (EPSON ES-1200) using gel analysis software (NIH Image 1.60).
RESULTS AND DISCUSSION
Yama/CPP32 and ICE-LAP3 are members of the ced-3/ICElike proteases. These proteases participate in propagation of the cell death program following proteolytic conversion from a proenzyme form (15, 16, 40) . The 32-kDa proYama/CPP32 is processed to active 24-kDa and 17-kDa forms (16) which cleave the DNA repair enzyme PARP present in cells undergoing apoptosis (15, 23, (25) (26) (27) . Similar proteolytic reduction to the active 20-kDa form also allows ICE-LAP3 to cleave PARP. Thus, Yama/CPP32 and ICE-LAP3 serve as markers for PCD propagation.
We have previously shown that hyperosmolar stress is a potent apoptotic stimulus for neural cells (28, 29, 41) . More than 60% of SH-SY5Y cells undergo DNA fragmentation (as quantitated by flow cytometry following propidium iodine staining) within 24 h after exposure to 300 mM mannitol (29, 41) . In the current, study we report that mannitol hyperosmolar shock rapidly induces conversion of proYama/CPP32 to Yama/CPP32 in SH-SY5Y cells. Appearance of signature 17-kDa Yama/CPP32 fragments are apparent in cell lysates within 6 h following exposure to 300 mM mannitol (Fig. 1A) . Fig. 1B compares protein lysates from SH-SY5Y cells treated for 6 or 24 h with 300 mM mannitol with or without the addition of 10 nM IGF-II. IGF-II blocks proteolytic processing of both Yama/CPP32 and ICE-LAP3, an effect which correlates with our previous findings that IGF-II can reduce mannitol-induced PCD 6-to 8-fold (29) . Addition of ␣-IR 3 , a blocking antibody specific for IGF-IR, inhibits IGF-II's effects on the proteolytic processing of both enzymes ( Fig. 2A) , confirming that specific activation of IGF-IR is necessary for IGF-II-mediated action (31) .
Substrate-specific activation of IGF-IR initiates intracellular signaling through both the mitogen-activated protein (MAP) kinase and phosphatidylinositol 3-kinase (PI-3K) signaling cascades (42) (43) (44) . Recent studies suggest a link between PI-3K activation and protection from PCD. Concentrations of insulin which are known to activate IGF-IR (42) prevent PCD in PC12 cells by activating PI-3K, independent of the MAP kinase pathway (45) . In parallel, the ability of insulin to prevent PCD in PC-12 cells is blocked by wortmannin, a specific inhibitor of
Time course of Yama/CPP32 processing following exposure to hyperosmolar injury. SH-SY5Y cells were exposed to 300 mM mannitol for the indicated times in hours. PAGE separated proteins were immunoblotted with the antibody to p17 Yama/CPP32. A, appearance of both 24-kDa and 17-kDa active proteolytic Yama fragments is noted within 3 h following exposure, reaching maximum by 6 h. B, exogenous IGF-II retards the proteolytic processing of Yama and ICE/ LAP3. SH-SY5Y cells were exposed for the indicated hours to DMEM alone or to DMEM Ϯ 300 mM mannitol (MANN) Ϯ 10 nM IGF-II (MANNϩIGF-II). PAGE-separated proteins were immunoblotted with the antibody to p17 Yama/CPP32 or with antibody to p20 ICE/LAP3 as indicated. Results in A and B are representative of experiments performed 3 times.
FIG. 2. Hyperosmolar induced Yama processing in the presence of IGF-II plus blockers of IGF-IR-mediated cell signaling.
SH-SY5Y cells were exposed for 6 h to DMEM alone or DMEM in the presence of the IGF-IR blocking antibody ␣-IR 3 , 1 g/ml (A) or 300 mM MANN, or MANN plus 3 mM IGF-II, or MANN plus IGF-II plus ␣-IR 3 .
Immunoblot analysis was performed with antibody to the p17 fragment of Yama/CPP32. B, identical conditions were used as in A, but the PI-3K inhibitor wortmannin, 100 nM, was substituted for ␣-IR 3 . Both agents block the ability of IGF-II to inhibit Yama processing. Results shown are representative of experiments performed 3 times.
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PI-3K (45) . Using Yama/CPP32 conversion as a marker of PCD, we find that 100 nM wortmannin blocks the protective effect of 10 nM IGF-II 6 h following mannitol exposure (Fig. 2B) . Wortmannin alone induces neither PCD nor proteolytic cleavage of Yama. In contrast, we find that PD98059, an inhibitor of MAP kinase kinase 1 and 2 (MEK1, MEK2) (46) inhibits ERK activation in SH-SY5Y cells but had no effect on the ability of IGF-I to rescue neurons from hyperosmotic coupled PCD (data not shown). Taken together, these results suggest that PI-3K signaling is essential to IGF-IR mediated PCD protection, and that the site of IGF-IR mediated prevention of PCD occurs prior to (or "upstream of") processing of Yama/CPP32 and other ICE-like proteases involved in propagation of the death program.
Bcl-2, and the structurally related proteins Bcl-x L and Bax, are theorized to act as regulators of susceptibility to PCD in response to cellular injury, and function upstream of Yama and ICE-LAP3 to control PCD initiation (21) . Bcl-2 is highly expressed in the developing nervous system (47) and Bcl-2 overexpression leads to nervous system hypertrophy (48) . Similar enhancement of neuronal survival by Bcl-2 has been observed in several in vitro studies (49 -53) . With maturation, central nervous Bcl-2 expression appears to be replaced by Bcl-x L (12, 47) . Bcl-x L also protects cells from PCD, and cotransfection with Bcl-2 does not increase protection, suggesting that Bcl-2 and Bcl-x L share homologous mechanisms of action (12) . mRNA for Bcl-x L is exclusively expressed in mature postmitotic neurons (12) , and targeted disruption of Bcl-x L during embryogenesis results in massive death of neurons (54) . Two homologues of the Bcl family, Bax and Bak, enhance PCD and antagonize the protective effects of Bcl-2 and Bcl-x L (2, 13). Bcl-2 and Bcl-x L heterodimerize with Bax; it is this heterodimerization which is necessary to suppress PCD (13) . The ratio of Bcl-2 or Bcl-x L to Bax determines the susceptibility of a cell to PCD (13): high Bcl-2/Bax ratios are predictive of neuronal survival while low ratios accelerate PCD (25, (55) (56) (57) .
To examine a possible role for IGF-IR signaling in Bcl protein regulation, we used immunoblot analysis of cellular lysates to probe for changes in total cellular pools of Bcl-2, Bcl-x L , and Bax prior to and 24 h following treatment of SH-SY5Y cells with 300 mM mannitol with or without 10 nM IGF-II (Fig. 3) . Densitometric analysis of Fig. 3 immunoblots indicates that mannitol treatment induced a 4-fold decrease in total cellular Bcl-2 (as a fraction of total cellular protein), consistent with reports that decreased transcription of Bcl-2, and most other cellular genes, accompanies neuronal PCD (58 -61). This reduction is prevented by addition of IGF-II. Cellular Bcl-x L pool is reduced 40 -60%, while total cellular Bax is reduced less than 20%. Collectively, these results suggest that short-term IGF-IR signaling results in regulation at or above the level of Bcl-2 transcription to sustain Bcl-2 expression and may inhibit PCD, in part, by preventing lethal changes in cellular Bcl-2/ Bax ratios.
The role of IGF or other growth factors on long-term regulation of Bcl proteins is poorly studied. To address this question, we examined human neuroblastoma SHEP cells transfected with human IGF-IR cDNA in either correct (FBϩ2) or reverse (FCϪ4) orientation. FBϩ2 expresses approximately 6 times the cell surface IGF-IR abundance of the SHEP parent line, as measured by flow cytometry analysis following IGF-IR specific antibody staining (29) . FCϪ4 demonstrates IGF-IR abundance equivalent to parent SHEP cells (29) .
Total cellular pools of Bcl-2, Bcl-x L , and Bax were compared for SH-SY5Y, FBϩ2, and FCϪ4 during log phase growth in appropriate growth media as described under "Materials and Methods." Overexpression of IGF-IR in FBϩ2 correlated with a 2-3-fold increase in total FBϩ2 cellular Bcl-x L , while Bcl-x L concentration in control transfectant FCϪ4 remained unchanged (Fig. 4) . A similar fold increase in Bcl-x L was also observed in FBϩ4, an IGF-IR transfectant clone which expresses approximately 4 times the cell surface IGF-IR as the parent SHEP line (29) (data not shown). Bax and Bcl-2 concentrations were similar for FBϩ2 and FCϪ4, but when compared to SH-SY5Y cells, both transfectants expressed at least 10-fold lower levels of Bcl-2. Following treatment with 300 mM mannitol, both FCϪ4 and FBϩ2 showed a decrease in relative cellular Bcl-2, as described above for SH-SY5Y (data not shown).
Our results suggest that IGF-IR overexpression may have a separable, long-term effect in promoting resistance to PCD by increasing total cellular concentrations of Bcl-x L . This idea is supported by the expression pattern of Bcl proteins during nervous system development. Bcl-2 expression is highest in rapidly dividing neuroblasts (12, 47) . However, differentiation to mature, postmitotic neurons correlates with an increase in both cell surface IGF-IR and Bcl-x L (12, 48) , and high central nervous system neuronal expression of IGF-IR and Bcl-x L persists throughout adult life (62) . In parallel, recent preliminary studies indicate that chronic activation of nerve growth factor receptors in PC12 cells also results in up-regulation of Bcl proteins (63) .
CONCLUSIONS
In summary, IGF-IR activation blocks hyperosmotic coupled PCD in neuroglia (28, 29) . We examined whether IGF-IR activation effected either the negative regulators of the death pathway, Bcl-2, Bcl-x L , and Bax, or altered the function of the (expressing 6-fold more cell surface IGF-IR than FCϪ4) were grown to 90% confluence in DMEM with 10% CS. Protein lysates were extracted, and 60 g of total cellular protein for each sample was separated by PAGE and subjected to immunoblot analysis using specific antibodies to Bclx L , Bcl-2, or Bax. Results shown are representative of experiments performed 3 times.
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ced-3/ICE-like proteases. We found that osmotic stress decreased total neuronal Bcl-2 by 4-fold and correlated with proteolytic processing of ced-3/ICE-like proteases. IGF-IR activation prevented changes in Bcl-2 protein and IGF-IR:PI-3K signaling blocked ICE-LAP3 and Yama/CPP32 processing. Finally, increased neuronal IGF-IR expression enhanced the negative death regulator Bcl-x L . Collectively, our data suggest that IGF-IR signaling exerts its short-term inhibitory effects upon PCD "upstream" of both Bcl proteins and ced-3/ICE-like proteases, while chronic increased IGF-IR expression may modulate susceptibility to death signals by mediating the negative death regulator, Bcl-x L .
